首页>
外国专利>
MUPARFOSTAT FOR USE IN TREATING PATIENTS WITH HEPATITIS VIRUS-RELATED HEPATOCELLULAR CARCINOMA AFTER SURGICAL RESECTION
MUPARFOSTAT FOR USE IN TREATING PATIENTS WITH HEPATITIS VIRUS-RELATED HEPATOCELLULAR CARCINOMA AFTER SURGICAL RESECTION
展开▼
机译:MUPARFOSTAT手术切除后用于治疗肝炎病毒相关的肝细胞癌的患者
展开▼
页面导航
摘要
著录项
相似文献
摘要
Muparfostat for use in reducing intrahepatic tumor recurrence and increasing disease-free survival period in a hepatocellular carcinoma patient with microvascular invasion after curative liver resection, while excluding HCC patients with no vascular invasion and HCC patients with macrovascular invasion, is disclosed. The hepatocellular carcinoma patient with microvascular invasion is identified by examining a resected liver tumor sample from the HCC patient for the presence of microvascular invasion in the sample.
展开▼